Skip to main content

White Paper: Market access for in-vitro diagnostic tests in Europe

Get insights from MTRC White Papers to advance your understanding of European market access for IVD tests

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

UK Pathology Transformation Review 2026

In July 2026, an independent review of UK pathology services, commissioned by the Institute of Biomedical Science (IBMS) and chaired by Lord Carter of Coles, was published.

The review assesses the performance and transformation of UK pathology services. Its central focus is whether existing pathology service models are sufficiently integrated, well governed, digitally enabled, appropriately staffed, and transparently funded to meet rising demand. It covers seven main areas: international experience, the devolved UK nations, quality, workforce, patient access, digital and diagnostic infrastructure, and value and funding.

The report compares the UK with systems in France, Germany, and Australia. It examines how integrated laboratory models, national test-pricing arrangements, accreditation, automation, logistics, and digital infrastructure affect service performance. France is considered the principal case study of a mature, integrated pathology system.

The review found that pathology activity in England is rising, but the system does not yet have a consistent national framework for defining, counting, costing, or pricing tests. Funding remains fragmented across block contracts, local arrangements, ad-hoc program allocations, and wider NHS Payment Scheme flows.

To address this, the review proposes moving pathology towards more activity-aligned funding where appropriate. Its preferred initial approach is to develop and publish a shadow price-per-test tariff, beginning with community and GP-requested testing. This would allow proposed rates to be tested, validated, and recalibrated before any live implementation.

This review does not recommend another structural reorganization of pathology services. Instead, it calls for existing service models to be made operationally complete: one management structure, shared standards, unified governance, interoperable systems, and common quality controls across sites.

The review sets out six system-wide priorities for implementation:

  • Complete operational integration: every service model should operate as a single managed service, with shared standards, unified governance, and aligned digital and quality controls across sites.
  • Create a single, comparable national dataset across quality, workforce, access, digital, and value, with standard definitions for turnaround, incidents, workforce, activity and cost, and use it to support the development of a shadow price-per-test tariff.
  • Build workforce resilience by strengthening workforce planning, training capacity, advanced practice, and flexible deployment across service models.
  • Align digital, workforce, and funding reform as one implementation program, not separate workstreams, including the move towards activity-aligned funding through a price-per-test tariff model where appropriate.
  • Embed clear service model-level accountability for performance, with defined escalation routes where standards are not met.
  • Reinvest to sustain resilience, using value released through integration, automation, and procurement discipline to strengthen the workforce, digital infrastructure, specialist capacity, and long-term resilience.

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.